540726 TTFL

Trident Texofab Share Price

₹177.00 -3.8 (-2.1%)

23 Feb, 2025 04:05

SIP TrendupStart SIP in TTFL

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 4.36%
  • Over 3 Month + 65.19%
  • Over 6 Month + 308.78%
  • Over 1 Year + 177.08%
SIP Lightning

Smart Investing Starts Here Start SIP with Trident Texofab for Steady Growth!

Invest Now

Trident Texofab Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Trident Texofab Financials

Trident Texofab Technicals

EMA & SMA

Current Price
₹177.00
-3.8 (-2.1%)
pointer
  • stock-down_img
  • Bearish Moving Average 1
  • stock-up_img
  • Bullish Moving Average 15
  • 20 Day
  • ₹169.97
  • 50 Day
  • ₹159.60
  • 100 Day
  • ₹136.99
  • 200 Day
  • ₹109.01

Resistance and Support

178.75 Pivot Speed
  • R3 193.45
  • R2 189.20
  • R1 183.00
  • S1 172.55
  • S2 168.30
  • S3 162.10

What's your outlook on Trident Texofab?

You can only vote for once

Trident Texofab Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-03 Quarterly Results
2024-10-23 Others
2024-10-12 Quarterly Results
2024-07-18 Quarterly Results (Revised) issue in the ratio of 14:10 of Rs. 10/-
2024-05-25 Audited Results (Revised) issue in the ratio of 14:10 of Rs. 10/-

Trident Texofab F&O

Trident Texofab Shareholding Pattern

No data available.

About Trident Texofab

  • NSE Symbol
  • TTFL
  • BSE Symbol
  • 540726
  • ISIN
  • INE071Y01013

Similar Stocks to Trident Texofab

Trident Texofab FAQs

Trident Texofab share price is ₹177 As on 23 February, 2025 | 03:51

The Market Cap of Trident Texofab is ₹181.9 Cr As on 23 February, 2025 | 03:51

The P/E ratio of Trident Texofab is 95.9 As on 23 February, 2025 | 03:51

The PB ratio of Trident Texofab is 11 As on 23 February, 2025 | 03:51

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23